Extensive population-based studies on a popular group of drugs used to treat type 2 diabetes revealed no association with acute pancreatitis, but increased risk of bile duct and gallbladder disease
Category:
Published on: 1 Aug 2016
By Fergus Grieve, McGill Newsroom
Depression, metabolic factors combine to boost risk of developing diabetes, study finds
Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.
Published on: 12 Apr 2016
